Profil Financier
Gong Hongjia & family occupe actuellement le rang #236 du classement mondial StarFortune (secteur finance & investissement). Fortune nette estimée : $13.4 B (-$1 M sur 24h).
Investor Gong Hongjia's fortune mainly comes from his stake in Hangzhou Hikvision Digital Technology, a supplier of surveillance products.
He served as Hikvision's vice chairman until 2021 and is still its biggest individual shareholder.
Gong is the chairman of Vcanbio Cell & Gene Engineering, a Shanghai-listed company engaged in the preparation, detection and storage of stem cells.
He bought a 2.4% stake in C-Mer Eye Care Holdings, a Chinese medical services provider, in 2022.
He is also an investor in Shenzhen-based AI drug discovery startup Xtalpi, also known as QuantumPharm, which listed on the Hong Kong Stock Exchange in 2024.
Gong holds permanent residency in Hong Kong.